|
Video: What is a Stock Split?
|
|
Kymera Therapeutics is a biopharmaceutical company focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. Co.'s proprietary targeted protein degradation platform, which Co. refers to as Pegasus, allows Co. to discover selective small molecule protein degraders with activity against disease-causing proteins throughout the body. Co. has utilized its Pegasus platform to design protein degraders focused in the areas of immunology-inflammation and oncology, and Co. continues to apply its platform's capabilities to additional therapeutic areas. According to our Kymera Therapeutics stock split history records, Kymera Therapeutics has had 0 splits. | |
|
Kymera Therapeutics (KYMR) has 0 splits in our Kymera Therapeutics stock split history database.
Looking at the Kymera Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Kymera Therapeutics shares, starting with a $10,000 purchase of KYMR, presented on a split-history-adjusted basis factoring in the complete Kymera Therapeutics stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
08/24/2020 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$28.44 |
|
End price/share: |
$40.20 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
41.35% |
|
Average Annual Total Return: |
10.11% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$14,136.67 |
|
Years: |
3.59 |
|
|
|
|
|